Join the Skin Cancer group to help and get support from people like you.
Skin Cancer News (Page 3)
Related terms: Cancer, Skin
Vitamin D Might Ease the Agony of Psoriasis
TUESDAY, July 25, 2023 – People who have psoriasis may want to get their vitamin D levels checked. New research suggests that blood levels of the so-called "sunshine vitamin" may affect the severity...
Melanoma Presentation, Mortality Varies by Race
MONDAY, July 24, 2023 – Patterns of melanoma presentation, disease severity, and mortality vary by race, according to a research letter published online July 11 in the Journal of the American...
Need Vitamin D, But Need to Watch the Sun? Here's How You Do It
FRIDAY, July 21, 2023 – Your body needs vitamin D, the "sunshine" vitamin, but too much time in the sun can increase your risk for skin cancer. An expert offers tips for boosting vitamin D intake...
Summer Skin Care Tips for Those With Darker Skin
SUNDAY, July 16, 2023 – Dermatologist Dr. Caroline Opene is often asked if certain types of sun blocks are better for people with darker skin. Not necessarily, says the director of the University of...
Melanoma an Even More Deadly Disease in Black Men
WEDNESDAY, July 12, 2023 – Black men are more likely to die of melanoma, new research shows, and one reason why may be the unusual places where the deadly skin cancer is likely to show up on their...
'Browning Lotions' Are the Latest Summertime Trend, But Are They Safe?
WEDNESDAY, July 5, 2023 – People are using “browning lotions” to tan quickly, but experts are questioning the safety of this trend driven by social media influencers. Browning lotions work with the s...
Lower Extremities Have Highest Surgical Site Infection Rates With Mohs Surgery
WEDNESDAY, July 5, 2023 – Lower extremities have the highest rates of surgical site infections following Mohs micrographic surgery (MMS), according to a research letter published online June 24 in...
FDA Approves Libtayo (cemiplimab-rwlc) for Advanced Cutaneous Squamous Cell Carcinoma
September 28, 2018 – The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous...
FDA Approves Mektovi (binimetinib) and Braftovi (encorafenib) in Combination for Unresectable or Metastatic Melanoma with BRAF Mutations
On June 27, 2018, the Food and Drug Administration approved encorafenib and binimetinib (Braftovi and Mektovi, Array BioPharma Inc.) in combination for patients with unresectable or metastatic...
Array BioPharma Announces FDA Approval of Braftovi (encorafenib) in Combination with Mektovi (binimetinib) for Unresectable or Metastatic Melanoma with BRAF Mutations
BOULDER, Colo., June 27, 2018 /PRNewswire/ – Array BioPharma Inc. (Nasdaq: ARRY) today announced that the U.S. Food and Drug Administration (FDA) has approved Braftovi capsules in combination with...
FDA Expands Approval of Yervoy (ipilimumab) to Include Pediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma
PRINCETON, N.J.--(BUSINESS WIRE) July 24, 2017 --Bristol-Myers Squibb Company (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) has expanded the indication for Yervoy...
FDA Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
March 23, 2017 – The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic...
Biofrontera Announces U.S. FDA Approval of Ameluz and Activating BF-RhodoLED Device for Treatment of Actinic Keratosis
Leverkusen, Germany, May 11, 2016 – Biofrontera AG (FSE: B8F), the specialist for the treatment of sun-induced skin cancer, today announced that the U.S. Food and Drug Administration (FDA) has g...
FDA Approves Yervoy to Reduce the Risk of Melanoma Returning after Surgery
October 28, 2015 – Today the U.S. Food and Drug Administration expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma, to...
FDA Approves Imlygic (talimogene laherparepvec) for the Treatment of Melanoma
October 27, 2015 – The U.S. Food and Drug Administration today approved Imlygic (talimogene laherparepvec), the first FDA-approved oncolytic virus therapy, for the treatment of melanoma lesions in...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Basal Cell Carcinoma, Melanoma, Cancer